Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Facial Injectable Companies

ID: MRFR/MED/0998-CR
104 Pages
Nidhi Mandole
Last Updated: February 16, 2025
Facial injectables refer to various products that are injected into the skin to enhance facial aesthetics, reduce wrinkles, and restore volume. These products include dermal fillers and neuromodulators.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Facial Injectable Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)10.06%
2024 Market Size$ 12.69 Billion
2025 Market Size$ 14.11 Billion
2035 Market Size$ 36.58 Billion
Key Players
Companies such as Allergan
Revance Therapeutics
Medytox
Ipsen
Galderma
Hugel
Trends
  • Technological Advancements in Formulations
  • Growing Acceptance of Non-Surgical Procedures
  • Influence of Social Media on Beauty Standards
Opportunities
  • Expansion of Distribution Channels
  • Rising Demand for Aesthetic Procedures
  • Regulatory Support and Safety Standards
Summary Table of Contents Segmentation Methodology Download PDF

Top Industry Leaders in the Facial Injectable Market

Facial Injectable Key CompaniesLatest Facial injectables Companies Update
  • May 2023: U.S. Food and Drug Administration clearance of SKINVIVE by JUVÉDERM to enhance the smoothness of the skin on the cheeks in people over the age of 21.1 was announced by Allergan Aesthetics, a division of AbbVie (NYSE: ABBV). Smoother skin may be yours in as little as one treatment with SKINVIVETM by JUVÉDERM, the first and only hyaluronic acid (HA) intradermal microdroplet injection accessible in the United States. Smooth and injectable HA gel, SKINVIVE by JUVÉDERM has a minimal dose of local anesthetic (lidocaine). Unlike other facial injectables that enhance and enlarge the treated region, SKINVIVE by JUVÉDERM improves skin quality in the cheeks by smoothing the skin and boosting moisture. SKINVIVE by JUVÉDERM fills a significant void in the skin quality market with its specially formulated, silky, moisturizing gel that sinks in quickly and is safe for all Fitzpatrick Skin Types I-VI, from the fairest to the darkest.
  • March 2023: Galderma announced today the debut of FACE by Galderma™, a breakthrough aesthetic visualization tool powered by augmented reality (AR) that allows aesthetic experts and patients to view injectable treatment results* at the planning stage before treatment begins. This novel approach provides patients with a virtual "before and after" picture of their potential treatment outcomes, which can help allay their fears regarding injectable results. Patients may get a sneak peek at how injectable treatments like Restylane and Sculptra could improve or restore face characteristics with the real-time, simulated outcomes function.
List of Facial Injectables Key companies in the market

  • Eisai Co. Ltd (Japan)

  • Antares Pharma (U.S.)

  • AstraZeneca (U.K.)

  • Becton Dickinson and Company (U.S.)

  • Eli Lilly and Company (U.S.)

  • F. Hoffmann-La Roche AG (Switzerland)

  • Johnson and Johnson Services Inc. (U.S.)

  • Mylan N. V. (U.S.)

  • Novartis AG (Switzerland)

  • Novo Nordisk (Denmark)

  • Pfizer Inc. (U.S.)

  • Sanofi (France)

  • Teva Pharmaceutical Industries Ltd. (Israel)

Related Reports

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035